Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications

被引:33
|
作者
Kim, H. Jeffrey [1 ,2 ,6 ]
Hagan, Marygrace [3 ]
Butman, John A. [4 ]
Baggenstos, Martin [3 ]
Brewer, Carmen [1 ,2 ]
Zalewski, Christopher [1 ,2 ]
Linehan, W. Marston [5 ]
Lonser, Russell R. [3 ]
机构
[1] Natl Inst Deafness & Other Commun Disorders, Off Clin Director, NIH, Bethesda, MD USA
[2] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Bethesda, MD USA
[3] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA
[5] NIH, Urol Oncol Branch, Natl Canc Ctr, Bethesda, MD 20892 USA
[6] Georgetown Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Washington, DC 20007 USA
来源
LARYNGOSCOPE | 2013年 / 123卷 / 02期
基金
美国国家卫生研究院;
关键词
Endolymphatic sac tumor; von Hippel-Lindau; hearing loss; outcome; vertigo; surgery; MORBID HEARING-LOSS; COCHLEAR IMPLANTATION; TEMPORAL BONE; ADENOCARCINOMA; ORIGIN; GENE;
D O I
10.1002/lary.23646
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: To define the surgical treatment and outcomes of von Hippel-Lindau (VHL) disease-associated endolymphatic sac tumors (ELSTs), we analyzed consecutive VHL patients who underwent ELST resection. Study Design: Retrospective investigation of consecutive VHL patients who underwent resection of ELSTs at a clinical research center between 1999 and 2010. Methods: Analysis of serial clinical examinations, audiograms, imaging studies, and operative findings were analyzed. Results: Thirty-one consecutive patients with ELSTs (15 males, 16 females) underwent resection of 33 tumors (mean follow-up, 49.9 +/- 48.0 months; range, 1.0116 months). One patient had bilateral ELST resections and one patient underwent reoperation for recurrence. Mean age at surgery was 38.2 +/- 10.2 years (range, 1267 years). Whereas 29 ears (88%) had direct radiographic evidence of an ELST, four ears (12%) did not. Mean tumor size was 1.3 +/- 1.1 cm (range, 0.25.2 cm). Whereas two patients (two ears, 6%) were asymptomatic, 29 patients (31 ears, 94% of ears) had associated audiovestibular symptoms, including sensorineural hearing loss (28 ears, 84%), tinnitus (24 ears,73%), and vertigo (21 patients, 68%). Postoperatively, hearing was stabilized (27) or improved (three) in 97% of 31 ears. Complete tumor resection was achieved in 30 ears (91% of 33 ears). Complications included cerebrospinal fluid leak in two ears (6%) and transient lower cranial nerve palsy in one ear (3%). Conclusions: Surgical resection of ELSTs can be performed with hearing preservation and a reduction in audiovestibular dysfunction. Early surgical resection can prevent or decrease disabling audiovestibular symptoms, enhance the opportunity for complete resection, and preserve hearing. Laryngoscope, 2012
引用
收藏
页码:477 / 483
页数:7
相关论文
共 50 条
  • [31] VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease
    Kawahara, N
    Kume, H
    Ueki, K
    Mishima, K
    Sasaki, T
    Kirino, T
    NEUROLOGY, 1999, 53 (01) : 208 - 210
  • [32] Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome
    Megerian, CA
    Haynes, DS
    Poe, DS
    Choo, DI
    Keriakas, TJ
    Glasscock, ME
    OTOLOGY & NEUROTOLOGY, 2002, 23 (03) : 378 - 387
  • [33] VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease
    Vortmeyer, AO
    Choo, D
    Pack, S
    Oldfield, E
    Zhuang, ZP
    NEUROLOGY, 2000, 55 (03) : 460 - 460
  • [34] Re: Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in Von Hippel-Lindau disease
    Torres, Jairo I.
    Megerian, Cliff A.
    OTOLOGY & NEUROTOLOGY, 2007, 28 (08) : 1159 - 1159
  • [35] Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in Von Hippel-Lindau disease - In reply
    Kim, H. Jeffrey
    Lonser, Russell R.
    OTOLOGY & NEUROTOLOGY, 2007, 28 (08) : 1161 - 1161
  • [36] Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease:: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1α expression
    Jensen, RL
    Gillespie, D
    House, P
    Layfield, L
    Shelton, C
    JOURNAL OF NEUROSURGERY, 2004, 100 (03) : 488 - 497
  • [37] Conservative management of endolymphatic sac tumors in von Hippel–Lindau disease: case report
    Matthieu Peyre
    Stephan Gaillard
    Remy van Effenterre
    Sophie Giraud
    Stéphane Richard
    Acta Neurochirurgica, 2011, 153 : 42 - 47
  • [38] Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status
    Bambakidis, NC
    Megerian, CA
    Ratcheson, RA
    OTOLOGY & NEUROTOLOGY, 2004, 25 (05) : 773 - 781
  • [39] A histopathological connection between a fatal endolymphatic sac tumour and von Hippel-Lindau disease from 1960
    Bellairs, J. A.
    Gluth, M. B.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2018, 132 (01): : 75 - 78
  • [40] Endolymphatic sac tumours and von Hippel-Lindau disease - case report, molecular analysis and histopathological characterization
    Krzystolik, K.
    Cybulski, C.
    Sagan, L.
    Nowacki, P.
    Lubinski, J.
    FOLIA NEUROPATHOLOGICA, 2009, 47 (01) : 75 - 80